Tommy Alfaro-Moya

10PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 29, 2026
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation.

|Feb 26, 2026
Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia.

Nihar Desai, Mohammed Althobaiti, Carol Chen

|Dec 05, 2025
Impact of graft-versus-host disease prophylaxis strategies on GvHD-free/relapse-free survival in young adults undergoing unrelated donor allogeneic haematopoietic cell transplantation: A propensity score-matched analysis.

Nihar Desai, Sergio Rodriguez Rodriguez, Eshrak Al-Shaibani

|Oct 24, 2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival.

Sergio Rodriguez-Rodriguez, Nihar Desai, Christopher Lemieux

|May 08, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms.

Nihar Desai, Sergio Rodriguez-Rodriguez, Carol Chen

|Apr 04, 2025
Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantation.

Tommy Alfaro Moya, Abel Santos Carreira, Shiyi Chen

Pageof 2

Frequent Collaborators

8 joint publications

Rajat Kumar

7 joint publications

Ivan Pasic

7 joint publications

Eshrak Al-Shaibani

6 joint publications

Dennis Kim